CN Stock MarketDetailed Quotes
300439 Medicalsystem Biotechnology
- 11.27
- +0.10+0.90%
Market Closed Dec 20 15:00 CST
4.33BMarket Cap17.23P/E (TTM)
11.32High11.08Low34.37KlotVolume11.15Open11.17Pre Close38.63MTurnover1.18%Turnover Ratio16.87P/E (Static)383.95MShares13.2452wk High1.50P/B3.29BFloat Cap7.1552wk Low13.40Limit Up291.73MShs Float77.92Historical High8.94Limit Down2.15%Amplitude7.15Historical Low0.13Dividend TTM11.24Avg Price16.80KlotAsk1.19%Div YieldTTM100Lot Size16.89KlotBid
Medicalsystem Biotechnology Key Stats
EPS
According to the latest financial report of Medicalsystem Biotechnology, the latest earnings per share (TTM) for the company is 0.58. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: CNY
Cumulative Quarterly
Loading...
BVPS
Analyzing a company's fundamentals? Check out Medicalsystem Biotechnology's latest financial report to see how much their book value per share (BVPS) is currently at 7.52.
Currency: CNY
Cumulative Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Medicalsystem Biotechnology shows that the company's current ratio is 3.07, indicating healthy liquidity.
Currency: CNY
Cumulative Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Medicalsystem Biotechnology, the quick ratio is 2.62, indicating that the company can meet its short-term debt obligations.
Currency: CNY
Cumulative Quarterly
Loading...
ROE
Want to learn more about the financial health of Medicalsystem Biotechnology? The latest ROE figure is 8.01%, indicating that the company has stable profitability.
Currency: CNY
Cumulative Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Medicalsystem Biotechnology, the total asset return on investment (ROA) is 6.33%.
Currency: CNY
Cumulative Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Medicalsystem Biotechnology's latest financial report to see how their gross margin is doing - currently at 45.80%.
Currency: CNY
Cumulative Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Medicalsystem Biotechnology, the net profit margin is 15.88%, which is a good sign for its profitability.
Currency: CNY
Cumulative Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
